UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049983
Receipt number R000056763
Scientific Title Psychological support and exercise intervention to increase resilience to life adaptation -single-center study of patients with hematopoietic tumors-
Date of disclosure of the study information 2023/01/10
Last modified on 2024/01/20 20:52:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Psychological support and exercise intervention to increase resilience to life adaptation
-single-center study of patients with hematopoietic tumors-

Acronym

Rehabilitation to increase the resilience of patients with hematopoietic tumors

Scientific Title

Psychological support and exercise intervention to increase resilience to life adaptation
-single-center study of patients with hematopoietic tumors-

Scientific Title:Acronym

Rehabilitation to increase the resilience of patients with hematopoietic tumors

Region

Japan


Condition

Condition

hematologic malignancy

Classification by specialty

Hematology and clinical oncology Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Examining the effects of interventions that combine exercise therapy and mindfulness training on resilience.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Connor-Davidson Resilience Scale

Key secondary outcomes

Profile of Mood States2
Autonomic nervous system
Attention bias score
Locomotor activity


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Exercise therapy
Mindfulness training

Interventions/Control_2

Exercise therapy

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

(1) Patients with hematopoietic tumors receiving chemotherapy or radiation therapy who were informed of their condition at least 2 weeks ago.
(2) Hematopoietic tumor patients prescribed occupational therapy.
(3) Patients with Performance Status of 2 or less.

Key exclusion criteria

(1) Patients with central illness.
(2) Patients with a history of mental illness such as depression and anxiety.
(3) Patients with cognitive decline.
(4) Patients with serious autonomic side effects from chemotherapy.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Tetsuya
Middle name
Last name Okihara

Organization

Saitama Medical University International Medical Center

Division name

Rehabilitation center

Zip code

350-1298

Address

1397-1, Yamane, Hidaka, Saitama

TEL

042-984-4367

Email

to4601@5931.saitama-med.ac.jp


Public contact

Name of contact person

1st name Tetsuya
Middle name
Last name Okihara

Organization

Saitama Medical University International Medical Center

Division name

Rehabilitation center

Zip code

350-1298

Address

1397-1, Yamane, Hidaka, Saitama

TEL

042-984-4367

Homepage URL


Email

to4601@5931.saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University International Medical Center, Center for Clinical Research Integrity (CCRI), Clinical Research IRB Secretariat

Address

1397-1, Yamane, Hidaka, Saitama

Tel

042-984-4367

Email

to4601@5931.saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 07 Month 13 Day

Date of IRB

2022 Year 07 Month 13 Day

Anticipated trial start date

2023 Year 01 Month 10 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Patient uptake, ongoing trial.


Management information

Registered date

2023 Year 01 Month 06 Day

Last modified on

2024 Year 01 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056763


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name